MediPharm Labs (TSE:LABS) Shares Down 11.8% – Time to Sell?

MediPharm Labs Corp. (TSE:LABSGet Free Report) traded down 11.8% during mid-day trading on Monday . The stock traded as low as C$0.08 and last traded at C$0.08. 451,145 shares changed hands during trading, an increase of 33% from the average session volume of 339,066 shares. The stock had previously closed at C$0.09.

MediPharm Labs Price Performance

The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The stock’s fifty day moving average price is C$0.08 and its 200-day moving average price is C$0.08. The firm has a market cap of C$33.20 million, a PE ratio of -2.76 and a beta of 0.88.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.

Read More

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.